Search Results - "TIMCHENKO, Nikolai A"

Refine Results
  1. 1
  2. 2

    Therapeutic Targeting of the GSK3β-CUGBP1 Pathway in Myotonic Dystrophy by Lutz, Maggie, Levanti, Miranda, Karns, Rebekah, Gourdon, Genevieve, Lindquist, Diana, Timchenko, Nikolai A, Timchenko, Lubov

    “…Myotonic Dystrophy type 1 (DM1) is a neuromuscular disease associated with toxic RNA containing expanded CUG repeats. The developing therapeutic approaches to…”
    Get full text
    Journal Article
  3. 3

    Activation of CDK4 Triggers Development of Non-alcoholic Fatty Liver Disease by Jin, Jingling, Valanejad, Leila, Nguyen, Thuy Phuong, Lewis, Kyle, Wright, Mary, Cast, Ashley, Stock, Lauren, Timchenko, Lubov, Timchenko, Nikolai A.

    Published in Cell reports (Cambridge) (19-07-2016)
    “…The development of non-alcoholic fatty liver disease (NAFLD) is a multiple step process. Here, we show that activation of cdk4 triggers the development of…”
    Get full text
    Journal Article
  4. 4

    Elimination of Age-Associated Hepatic Steatosis and Correction of Aging Phenotype by Inhibition of cdk4-C/EBPα-p300 Axis by Nguyen, Phuong, Valanejad, Leila, Cast, Ashley, Wright, Mary, Garcia, Jose M., El-Serag, Hashem B., Karns, Rebekah, Timchenko, Nikolai A.

    Published in Cell reports (Cambridge) (07-08-2018)
    “…The aging liver is affected by several disorders, including steatosis, that can lead to a decline of liver functions. Here, we present evidence that the…”
    Get full text
    Journal Article
  5. 5

    Intracellular signaling and hepatocellular carcinoma by Iakova, Polina, Timchenko, Lubov, Timchenko, Nikolai A

    Published in Seminars in cancer biology (01-02-2011)
    “…Abstract Liver cancer is the fifth most common cancer and the third most common cause of cancer related death in the world. The recent development of new…”
    Get full text
    Journal Article
  6. 6

    The reduction of SIRT1 in livers of old mice leads to impaired body homeostasis and to inhibition of liver proliferation by Jin, Jingling, Iakova, Polina, Jiang, Yanjun, Medrano, Estela E., Timchenko, Nikolai A.

    Published in Hepatology (Baltimore, Md.) (02-09-2011)
    “…Age declines liver functions, leading to the development of age‐associated diseases. A member of the sirtuins family, SIRT1, is involved in the control of…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Increased Expression of Enzymes of Triglyceride Synthesis Is Essential for the Development of Hepatic Steatosis by Jin, Jingling, Iakova, Polina, Breaux, Meghan, Sullivan, Emily, Jawanmardi, Nicole, Chen, Dahu, Jiang, Yanjun, Medrano, Estela M., Timchenko, Nikolai A.

    Published in Cell reports (Cambridge) (01-03-2013)
    “…Molecular mechanisms underpinning nonalcoholic fatty liver disease (NAFLD) are not well understood. The earliest step of NAFLD is hepatic steatosis, which is…”
    Get full text
    Journal Article
  9. 9

    Role of HDAC1 in senescence, aging, and cancer by Willis-Martinez, Danielle, Richards, Hunter W., Timchenko, Nikolai A., Medrano, Estela E.

    Published in Experimental gerontology (01-04-2010)
    “…HDAC1 is a member of the class I of histone deacetylases that also includes HDAC2, -3 and -8. Although HDAC1 has been mostly studied in the context of cancer,…”
    Get full text
    Journal Article
  10. 10

    Intravenous miR-144 inhibits tumor growth in diethylnitrosamine-induced hepatocellular carcinoma in mice by He, Quan, Wang, Fangfei, Honda, Takashi, Lindquist, Diana M, Dillman, Jonathan R, Timchenko, Nikolai A, Redington, Andrew N

    Published in Tumor biology (01-10-2017)
    “…Previous in vitro studies have demonstrated that miR-144 inhibits hepatocellular carcinoma cell proliferation, invasion, and migration. We have shown that…”
    Get full text
    Journal Article
  11. 11

    Aging and liver regeneration by Timchenko, Nikolai A

    Published in Trends in endocrinology and metabolism (01-05-2009)
    “…The loss of regenerative capacity is the most dramatic age-associated alteration in the liver. Although this phenomenon was reported over 50 years ago, the…”
    Get full text
    Journal Article
  12. 12

    Overexpression of CUG Triplet Repeat-binding Protein, CUGBP1, in Mice Inhibits Myogenesis by Timchenko, Nikolai A., Patel, Roma, Iakova, Polina, Cai, Zong-Jin, Quan, Ling, Timchenko, Lubov T.

    Published in The Journal of biological chemistry (26-03-2004)
    “…Accumulation of RNA CUG repeats in myotonic dystrophy type 1 (DM1) patients leads to the induction of a CUG-binding protein, CUGBP1, which increases…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Competition of CUGBP1 and calreticulin for the regulation of p21 translation determines cell fate by Iakova, Polina, Wang, Guo-Li, Timchenko, Lubov, Michalak, Marek, Pereira-Smith, Olivia M, Smith, James R, Timchenko, Nikolai A

    Published in The EMBO journal (28-01-2004)
    “…Induction of p21 in senescent human fibroblasts plays a key role in the inactivation of cyclin‐dependent kinases and the resulting irreversible growth arrest…”
    Get full text
    Journal Article
  15. 15

    Increased CUG Triplet Repeat-binding Protein-1 Predisposes to Impaired Adipogenesis with Aging by Karagiannides, Iordanes, Thomou, Thomas, Tchkonia, Tamara, Pirtskhalava, Tamar, Kypreos, Kyriakos E., Cartwright, Andrew, Dalagiorgou, Georgia, Lash, Timothy L., Farmer, Stephen R., Timchenko, Nikolai A., Kirkland, James L.

    Published in The Journal of biological chemistry (11-08-2006)
    “…Preadipocyte differentiation capacity declines between middle and old age. Expression of the adipogenic transcription factors, CCAAT/enhancer-binding protein…”
    Get full text
    Journal Article
  16. 16

    SKI knockdown inhibits human melanoma tumor growth in vivo by Chen, Dahu, Lin, Qiushi, Box, Neil, Roop, Dennis, Ishii, Shunsuke, Matsuzaki, Koichi, Fan, Tao, Hornyak, Thomas J., Reed, Jon A, Stavnezer, Ed, Timchenko, Nikolai A., Medrano, Estela E.

    Published in Pigment cell and melanoma research (01-12-2009)
    “…Summary The SKI protein represses the TGF‐β tumor suppressor pathway by associating with the Smad transcription factors. SKI is upregulated in human malignant…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20

    Reduction of Cellular Nucleic Acid Binding Protein Encoded by a Myotonic Dystrophy Type 2 Gene Causes Muscle Atrophy by Wei, Christina, Stock, Lauren, Schneider-Gold, Christiane, Sommer, Claudia, Timchenko, Nikolai A., Timchenko, Lubov

    Published in Molecular and cellular biology (01-07-2018)
    “…Myotonic dystrophy type 2 (DM2) is a neuromuscular disease caused by an expansion of intronic CCTG repeats in the CNBP gene, which encodes a protein regulating…”
    Get full text
    Journal Article